Viewing Study NCT06027892


Ignite Creation Date: 2025-12-24 @ 3:58 PM
Ignite Modification Date: 2025-12-29 @ 9:48 AM
Study NCT ID: NCT06027892
Status: RECRUITING
Last Update Posted: 2024-11-15
First Post: 2023-08-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer
Sponsor: Rabin Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: RMC-0199-22
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators